A major centre in London aims to test new treatments for brain diseases, it has been announced.
Some £20 million has been pumped into the project at University College London by the Wolfson Foundation.
Developers say their aim is to enable patients to test new treatments.
The first project, early next year, will test an immunotherapy treatment for familial Alzheimer’s disease, which can affect people in their 30s.
The centre has been named the Leonard Wolfson Experimental Neurology Centre and is in the National Hospital for Neurology and Neurosurgery.
Its principal investigator Professor Nick Fox said: “The highest priority for patients with neurodegenerative diseases is to find treatments that slow or halt the progress of the disease or delay its onset. These treatments should be offered as early as possible to minimise impact on loss of cognitive and neurological functions.
"Experience across medicine shows that treatment of advanced disease may come too late."
He added: "At the Leonard Wolfson Experimental Neurology Centre we aim to speed up the development and validation of treatments, and open an earlier window to patients through which we can provide treatment and try to minimise the damage caused by neurodegenerative disease."
Leave a Reply